Prediction and Classification of Alzheimer’s Disease Based on Combined Features From Apolipoprotein-E Genotype, Cerebrospinal Fluid, MR, and FDG-PET Imaging Biomarkers

Alzheimer's disease (AD), including its mild cognitive impairment (MCI) phase that may or may not progress into the AD, is the most ordinary form of dementia. It is extremely important to correctly identify patients during the MCI stage because this is the phase where AD may or may not develop. Thus, it is crucial to predict outcomes during this phase. Thus far, many researchers have worked on only using a single modality of a biomarker for the diagnosis of AD or MCI. Although recent studies show that a combination of one or more different biomarkers may provide complementary information for the diagnosis, it also increases the classification accuracy distinguishing between different groups. In this paper, we propose a novel machine learning-based framework to discriminate subjects with AD or MCI utilizing a combination of four different biomarkers: fluorodeoxyglucose positron emission tomography (FDG-PET), structural magnetic resonance imaging (sMRI), cerebrospinal fluid (CSF) protein levels, and Apolipoprotein-E (APOE) genotype. The Alzheimer's Disease Neuroimaging Initiative (ADNI) baseline dataset was used in this study. In total, there were 158 subjects for whom all four modalities of biomarker were available. Of the 158 subjects, 38 subjects were in the AD group, 82 subjects were in MCI groups (including 46 in MCIc [MCI converted; conversion to AD within 24 months of time period], and 36 in MCIs [MCI stable; no conversion to AD within 24 months of time period]), and the remaining 38 subjects were in the healthy control (HC) group. For each image, we extracted 246 regions of interest (as features) using the Brainnetome template image and NiftyReg toolbox, and later we combined these features with three CSF and two APOE genotype features obtained from the ADNI website for each subject using early fusion technique. Here, a different kernel-based multiclass support vector machine (SVM) classifier with a grid-search method was applied. Before passing the obtained features to the classifier, we have used truncated singular value decomposition (Truncated SVD) dimensionality reduction technique to reduce high dimensional features into a lower-dimensional feature. As a result, our combined method achieved an area under the receiver operating characteristic (AU-ROC) curve of 98.33, 93.59, 96.83, 94.64, 96.43, and 95.24% for AD vs. HC, MCIs vs. MCIc, AD vs. MCIs, AD vs. MCIc, HC vs. MCIc, and HC vs. MCIs subjects which are high relative to single modality results and other state-of-the-art approaches. Moreover, combined multimodal methods have improved the classification performance over the unimodal classification.

[1]  Nick C Fox,et al.  Biomarkers in dementia: clinical utility and new directions , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[2]  Goo-Rak Kwon,et al.  Alzheimer's Disease Diagnosis Based on Cortical and Subcortical Features , 2019, Journal of healthcare engineering.

[3]  Silvia Conforto,et al.  Automated Segmentation of Colorectal Tumor in 3D MRI Using 3D Multiscale Densely Connected Convolutional Neural Network , 2019, Journal of healthcare engineering.

[4]  Caroline Hayward,et al.  Cognitive ability at age 11 and 70 years, information processing speed, and APOE variation: the Lothian Birth Cohort 1936 study. , 2009, Psychology and aging.

[5]  Zoran Rumboldt,et al.  Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease. , 2011, Radiology.

[6]  Kaj Blennow,et al.  Cerebrospinal fluid protein biomarkers for Alzheimer’s disease , 2004, NeuroRX.

[7]  Kingshuk Roy Choudhury,et al.  Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. , 2013, Radiology.

[8]  Brian B. Avants,et al.  N4ITK: Improved N3 Bias Correction , 2010, IEEE Transactions on Medical Imaging.

[9]  Jeonghwan Gwak,et al.  Diagnosis of Alzheimer's Disease Based on Structural MRI Images Using a Regularized Extreme Learning Machine and PCA Features , 2017, Journal of healthcare engineering.

[10]  S. Burnham,et al.  Blood-based molecular biomarkers for Alzheimer’s disease , 2019, Molecular Brain.

[11]  Seong-Whan Lee,et al.  Hierarchical feature representation and multimodal fusion with deep learning for AD/MCI diagnosis , 2014, NeuroImage.

[12]  K. Blennow,et al.  Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer’s disease: a community based follow up study , 1998, Journal of neurology, neurosurgery, and psychiatry.

[13]  Timo Grimmer,et al.  Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer’s disease , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  H. Braak,et al.  Evolution of Alzheimer's disease related cortical lesions. , 1998, Journal of neural transmission. Supplementum.

[15]  Chunlan Yang,et al.  Structural MRI-based detection of Alzheimer's disease using feature ranking and classification error , 2016, Comput. Methods Programs Biomed..

[16]  A. Dale,et al.  Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease , 2010, American Journal of Neuroradiology.

[17]  Rebecca M. E. Steketee,et al.  Multiparametric computer-aided differential diagnosis of Alzheimer’s disease and frontotemporal dementia using structural and advanced MRI , 2016, European Radiology.

[18]  Ronald C Petersen,et al.  Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study. , 2011, Neuropsychology.

[19]  Samuel Kadoury,et al.  Classification of Alzheimer's and MCI Patients from Semantically Parcelled PET Images: A Comparison between AV45 and FDG-PET , 2018, Int. J. Biomed. Imaging.

[20]  Goo-Rak Kwon,et al.  Diagnosis of Alzheimer's Disease Using Dual-Tree Complex Wavelet Transform, PCA, and Feed-Forward Neural Network , 2017, Journal of healthcare engineering.

[21]  Rui Li,et al.  Multi-modal discriminative dictionary learning for Alzheimer's disease and mild cognitive impairment , 2017, Comput. Methods Programs Biomed..

[22]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[23]  Ghulam Muhammad,et al.  Development of the Arabic Voice Pathology Database and Its Evaluation by Using Speech Features and Machine Learning Algorithms , 2017, Journal of healthcare engineering.

[24]  Frédéric Jurie,et al.  Randomized Clustering Forests for Image Classification , 2008, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[25]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[26]  Corinna Cortes,et al.  Support-Vector Networks , 1995, Machine Learning.

[27]  Marie Chupin,et al.  Automatic classi fi cation of patients with Alzheimer ' s disease from structural MRI : A comparison of ten methods using the ADNI database , 2010 .

[28]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[29]  Gavin Brown,et al.  Ensemble Learning , 2010, Encyclopedia of Machine Learning and Data Mining.

[30]  M. Gilardi,et al.  Magnetic resonance imaging biomarkers for the early diagnosis of Alzheimer's disease: a machine learning approach , 2015, Front. Neurosci..

[31]  J. Morris The Clinical Dementia Rating (CDR) , 1993, Neurology.

[32]  Jesse S. Jin,et al.  Identification of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Multivariate Predictors , 2011, PloS one.

[33]  M. Greiner,et al.  Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. , 2000, Preventive veterinary medicine.

[34]  Bradford C. Dickerson,et al.  Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau , 2013, Front. Aging Neurosci..

[35]  Frederik Barkhof,et al.  Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease. , 2016, Radiology.

[36]  Xiaoying Wu,et al.  Structural and functional biomarkers of prodromal Alzheimer's disease: A high-dimensional pattern classification study , 2008, NeuroImage.

[37]  Rogier A. Feis,et al.  Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging. , 2018, Journal of Alzheimer's disease : JAD.

[38]  Yu Zhang,et al.  The Human Brainnetome Atlas: A New Brain Atlas Based on Connectional Architecture , 2016, Cerebral cortex.

[39]  Ninon Burgos,et al.  Reproducible evaluation of classification methods in Alzheimer's disease: Framework and application to MRI and PET data , 2018, NeuroImage.

[40]  M. Jorge Cardoso,et al.  Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment☆ , 2013, NeuroImage: Clinical.

[41]  K. Blennow,et al.  Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease , 2007, Annals of the New York Academy of Sciences.

[42]  X. Chen,et al.  Random forests for genomic data analysis. , 2012, Genomics.

[43]  L. Fratiglioni,et al.  Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.

[44]  Chunxiang Jiang,et al.  Prediction and classification of Alzheimer disease based on quantification of MRI deformation , 2017, PloS one.

[45]  Michael Wagner,et al.  Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia , 2017, Alzheimer's Research & Therapy.

[46]  Daoqiang Zhang,et al.  Domain Transfer Learning for MCI Conversion Prediction , 2012, MICCAI.

[47]  T. J. Grabowski,et al.  FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease , 2008 .

[48]  R. Elwood,et al.  The Wechsler Memory Scale—Revised: Psychometric characteristics and clinical application , 1991, Neuropsychology Review.

[49]  C. Jack,et al.  MRI and CSF biomarkers in normal, MCI, and AD subjects , 2009, Neurology.

[50]  Tijn M. Schouten,et al.  Combining anatomical, diffusion, and resting state functional magnetic resonance imaging for individual classification of mild and moderate Alzheimer's disease , 2016, NeuroImage: Clinical.

[51]  Hasan Demirel,et al.  Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm , 2017, Comput. Biol. Medicine.

[52]  S. Resnick,et al.  Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging , 2008, Neurobiology of Aging.

[53]  Gaël Varoquaux,et al.  Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..

[54]  L. McEvoy,et al.  Predicting MCI outcome with clinically available MRI and CSF biomarkers , 2011, Neurology.

[55]  Keith A. Johnson,et al.  A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers , 2016, Neurology.

[56]  Pierre Geurts,et al.  Extremely randomized trees , 2006, Machine Learning.

[57]  Anoop Arunagiri,et al.  CSF Biomarkers for Alzheimer's Disease Diagnosis , 2010, International journal of Alzheimer's disease.

[58]  H. Gertz,et al.  Alzheimer’s Disease — From Basic Research to Clinical Applications , 1998, Journal of Neural Transmission. Supplementa.

[59]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[60]  Ana Madevska Bogdanova,et al.  Probabilistic SVM outputs for pattern recognition using analytical geometry , 2004, Neurocomputing.

[61]  C. Jack,et al.  NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.

[62]  Christopher Rorden,et al.  The first step for neuroimaging data analysis: DICOM to NIfTI conversion , 2016, Journal of Neuroscience Methods.

[63]  J. Trojanowski,et al.  Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification , 2011, Neurobiology of Aging.

[64]  Daoqiang Zhang,et al.  Multimodal classification of Alzheimer's disease and mild cognitive impairment , 2011, NeuroImage.

[65]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[66]  Heikki Huttunen,et al.  Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects , 2015, NeuroImage.

[67]  R. Dixon,et al.  Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyle , 2017, Neurobiology of Aging.

[68]  Xiaoke Hao,et al.  Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer’s Disease Spectrum , 2015, Molecular Neurobiology.

[69]  C. DeCarli,et al.  FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. , 2007, Brain : a journal of neurology.

[70]  H. Rusinek,et al.  Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[71]  John Q. Trojanowski,et al.  Healthy brain aging: A meeting report from the Sylvan M. Cohen Annual Retreat of the University of Pennsylvania Institute on Aging , 2008, Alzheimer's & Dementia.

[72]  R. Petersen,et al.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.

[73]  H. Braak,et al.  Staging of alzheimer's disease-related neurofibrillary changes , 1995, Neurobiology of Aging.

[74]  Sébastien Ourselin,et al.  Fast free-form deformation using graphics processing units , 2010, Comput. Methods Programs Biomed..

[75]  Li Yao,et al.  Prediction of Mild Cognitive Impairment Conversion Using a Combination of Independent Component Analysis and the Cox Model , 2017, Front. Hum. Neurosci..

[76]  A. Dale,et al.  CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease , 2010, The Journal of Neuroscience.

[77]  Stuart W. S. MacDonald,et al.  APOE and COMT polymorphisms are complementary biomarkers of status, stability, and transitions in normal aging and early mild cognitive impairment , 2014, Front. Aging Neurosci..

[78]  Martina Sattlecker,et al.  Are blood-based protein biomarkers for Alzheimer's disease also involved in other brain disorders? A systematic review. , 2014, Journal of Alzheimer's disease : JAD.

[79]  R. Buchert,et al.  Multimodal prediction of conversion to Alzheimer's disease based on incomplete biomarkers∗ , 2015, Alzheimer's & dementia.

[80]  J B Poline,et al.  Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. , 2007, Brain : a journal of neurology.

[81]  Daoqiang Zhang,et al.  Predicting Future Clinical Changes of MCI Patients Using Longitudinal and Multimodal Biomarkers , 2012, PloS one.